ABCELLERA BIOLOGICS (8QQ) — Cash Flow Reinvestment Rate
ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Reinvestment Rate of 1.24x as of December 2022, reinvesting €343.38 Million (capex €72.66 Million plus investments €-270.72 Million) from operating cash flow of €277.36 Million. Explore ABCELLERA BIOLOGICS (8QQ) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ABCELLERA BIOLOGICS Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for ABCELLERA BIOLOGICS across 2 annual periods. Also explore ABCELLERA BIOLOGICS total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year capital reinvestment analysis for ABCELLERA BIOLOGICS. For live market cap and broader valuation context, see market value of ABCELLERA BIOLOGICS.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.24x | €343.38 Million | €277.36 Million | €72.66 Million | ▼ -6.3% |
| 2021 | 1.32x | €323.09 Million | €244.58 Million | €58.45 Million | — |